NHS Branded Medicines Tranche A - London & SOFE & Adult Influenza National

NHS England · awarded 25 June 2025

Who

Buyer	NHS England Runcorn
Suppliers	Accord-UK Ltd Amgen Ltd AstraZeneca Aventis Pharma ltd t/a Sanofi Bayer Plc Biogen CST Pharma Limited Chugai Pharma UK Ltd Dr.Reddy's Laboratories (UK) Limited Eli Lilly & Company Ltd Gedeon Richter UK Ltd GlaxoSmithKline UK Limited Janssen-Cilag Ltd Manx Healthcare Ltd Merck Serono Limited Mylan Napp Pharmaceuticals Ltd Novo Nordisk Orifarm UK Pfizer Ltd Pharmacosmos UK Ltd Roche Products Ltd Sandoz Ltd Seqirus UK Limited Sun Pharma UK Ltd Teva UK Limited Thornton and Ross Ltd Vifor Pharma UK Ltd
Category	goods
Classification	Pharmaceutical products CPV 33600000
Notice published	24 July 2025

What it is for

NHS Framework Agreement for Branded Medicines - Tranche A London and South of England and Adult Influenza (National) - 01 September 2025 Offer reference number: CM/PHR/24/5718 CM/PHR/24/5718/01 - NHS Framework Agreement for Branded Medicines - Tranche A for London and South of England. Period of Framework Agreement: 01 September 2025 to 31 August 2027 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. CM/PHR/24/5718/02 - NHS Framework Agreement for Branded Medicines - Adult Influenza (National). Period of Framework Agreement: 01 September 2025 to 31 August 2026 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 36 months.

Read the original award notice on Contracts Finder →

Other contracts from this buyer

1269 awards on file, worth £50.2bn.

Everything NHS England has awarded →

Other contracts won by this supplier

5 awards on file, worth £2.8bn.

Everything Roche Products Ltd has won →